According to attorneys, the U.S. Drug Enforcement Administration's new rule clarifying the illegality of marijuana extracts will not have a significant impact on Pennsylvania's medical marijuana industry—but it may prompt lawyers to advise their clients not to ship cannabis products interstate.
January 10, 2017 at 05:16 PM
1 minute read
According to attorneys, the U.S. Drug Enforcement Administration’s new rule clarifying the illegality of marijuana extracts will not have a significant impact on Pennsylvania’s medical marijuana industry—but it may prompt lawyers to advise their clients not to ship cannabis products interstate.
The DEA announced in December that, effective Jan. 13, marijuana extracts will be classified as Schedule I drugs—substances or chemicals with no medical use and a high potential for abuse.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
